These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9782067)

  • 1. Influence of baseline values on lipids and lipoprotein changes during amlodipine treatment of hypertension.
    Ahaneku JE
    Pharmacol Res; 1998 Sep; 38(3):179-82. PubMed ID: 9782067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during amlodipine treatment of hypertension in Japanese patients.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):75-9. PubMed ID: 10600272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of baseline values on lipids, lipoproteins and fibrinolytic parameters during treatment of hypertension with cilnidipine.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):81-4. PubMed ID: 10600273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients.
    Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
    J Pak Med Assoc; 1994 Jul; 44(7):166-9. PubMed ID: 7933456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING AMLODIPINE TREATMENT OF HYPERTENSION IN JAPANESE PATIENTS.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):73-77. PubMed ID: 10712829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INFLUENCE OF BASELINE VALUES ON LIPIDS, LIPOPROTEINS AND FIBRINOLYTIC PARAMETERS DURING TREATMENT OF HYPERTENSION WITH CILNIDIPINE.
    Ahaneku JE; Sakata K; Urano T; Takada Y; Takada A
    Pharmacol Res; 2000 Jan; 41(1):79-82. PubMed ID: 10712830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of amlodipine on plasma lipid and lipoprotein levels in hypertensive patients.
    Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Sowunmi A; Salako LA
    J Intern Med; 1992 Dec; 232(6):489-91. PubMed ID: 1474348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of baseline values. II: Variations in plasma lipoprotein fractions during doxazosin treatment for hypertension.
    Ahaneku JE; Taylor GO; Agbedana EO
    Int J Clin Pharmacol Res; 1998; 18(4):165-70. PubMed ID: 10052026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension.
    Ahaneku JE; Taylor GO; Agbedana EO; Walker O; Salako LA
    Int J Clin Pharmacol Res; 1998; 18(4):159-63. PubMed ID: 10052025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antihypertensive therapy on serum lipids in newly diagnosed essential hypertensive men.
    Nandeesha H; Pavithran P; Madanmohan T
    Angiology; 2009; 60(2):217-20. PubMed ID: 18445617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study).
    Erdine S; Ro YM; Tse HF; Howes LG; Aguilar-Salinas CA; Chaves H; Guindy R; Chopra P; Moller RA; Schou IM;
    J Hum Hypertens; 2009 Mar; 23(3):196-210. PubMed ID: 18800143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y; Gagné C
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertension.
    Christogiannis LG; Kostapanos MS; Tellis CC; Milionis HJ; Tselepis AD; Elisaf MS
    J Hum Hypertens; 2013 Jan; 27(1):44-50. PubMed ID: 22129607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients.
    Ahaneku JE; Taylor GO; Agbedana OE; Walker O; Salako LA
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):155-60. PubMed ID: 7701530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3.
    Hansel B; Girerd X; Bonnefont-Rousselot D; Bittar R; Chantepie S; Orsoni A; Bruckert E; Chapman MJ; Kontush A
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):317-25. PubMed ID: 21699274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olmesartan/amlodipine combination versus olmesartan or amlodipine monotherapies on blood pressure and insulin resistance in a sample of hypertensive patients.
    Derosa G; Cicero AF; Carbone A; Querci F; Fogari E; D'Angelo A; Maffioli P
    Clin Exp Hypertens; 2013; 35(5):301-7. PubMed ID: 22954201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome.
    Yilmaz MI; Sonmez A; Caglar K; Celik T; Yenicesu M; Eyileten T; Acikel C; Oguz Y; Yavuz I; Vural A
    Nephrology (Carlton); 2007 Apr; 12(2):147-53. PubMed ID: 17371337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correction of endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus during combined antihypertensive therapy].
    Statsenko ME; Derevianchenko MV
    Ter Arkh; 2014; 86(8):90-3. PubMed ID: 25306751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.